SEC Form 4 · accession 0001572426-15-000127
Nexvet Biopharma plc · NVET
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Damian T. Lismore
Officer — Chief Financial Officer
Period of report
Nov 17, 2015
Accepted (ET)
Nov 19, 2015 · 6:17 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001618561
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares | Nov 17, 2015 | M | 7,080 | $0.125 | A | 14,160 | I | By spouse |
| Ordinary Shares | holding | — | — | — | 10,000 | D | ||
| Ordinary SharesF1 | holding | — | — | — | 13,724 | I | Glenariff Superannuation Pty Ltd <Glenariff Super Fund A/C> |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Option to Purchase SharesF2 | $0.125 | Nov 17, 2015 | M | 7,080 | D | — | Nov 5, 2023 | Ordinary Shares | 7,080 | 7,079 | I |
Explanation of responses
- F1The reporting person and his spouse share voting and dispositive power with respect to these reported securities.
- F27,080 options to purchase shares vested and became exercisable on 11/5/15, and the remaining 7,079 options to purchase shares will vest and become exercisable on 11/5/16.